Insider · CIK 0001383556
Curtis Lockshin
Files at PHIO (Phio Pharmaceuticals Corp.). First filing -, latest -.
In brief
Curtis Lockshin files SEC Form 4 as director at PHIO (Phio Pharmaceuticals Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Curtis Lockshin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +16,600 | $0.00 | $0 | 35,155 | Feb 6, 2026 |
| Sep 11, 2025 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +16,200 | $0.00 | $0 | 18,555 | Sep 15, 2025 |
Questions about Curtis Lockshin
Answered from the filings on this page, as of the latest one.
Is Curtis Lockshin buying or selling?
Curtis Lockshin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Curtis Lockshin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Curtis Lockshin has 0.
Where does Curtis Lockshin file Form 4?
Curtis Lockshin has filed Form 4 at PHIO (Phio Pharmaceuticals Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.